- Report
- February 2026
- 580 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 428 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 213 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 179 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 504 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 193 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 292 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 402 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 657 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 146 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- January 2026
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- September 2025
- 300 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- July 2025
- 192 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- December 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP

High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more